Continue to site >
Trending ETFs
You have successfully subscribed to Advisor Access. Thank you!
Help us personalize your experience.
Which type of investor describes you best?
Help us personalize your experience.
What is your AUM?
Knowing your investable assets will help us build and prioritize features that will suit your investment needs.

Congratulations on personalizing your experience.

Email is verified. Thank you!

UnitedHealth to Buy Catamaran: What it Means For Mutual Fund Investors (UNH, CTRX)

Shauna O'Brien

|

UnitedHealth Group Inc. logo
Before Monday’s opening bell, UnitedHealth (UNH) reported that it will acquire Catamaran (CTRX). Here’s what the news means for mutual fund investors.

Inside the Deal

UnitedHealth reported its pharmacy business OptumRx has agreed to acquire Catamaran in a $12.8 billion deal, or $61.50 per share. The companies noted that this deal is expected to close in the fourth quarter.

UNH reported that the deal is expected to add 30 cents per share to earnings in 2016.

Merging Will Help the Companies Face Competition

In the merger deal, the two companies are aiming to obtain more favorable prices with pharmaceutical companies, as they face companies like Express Scripts and CVS. The deal will combine the fourth and third largest pharmacy-benefit companies in the U.S.

Mutual Funds to Watch

Investors interested in the two companies may be interested in the funds listed below. These funds currently have the largest stakes in the companies.

Funds Holding UnitedHealth

Symbol Mutual Fund Stake
{% mutualfund FLPSX %} Fidelity® Low-Priced Stock 2.29%
VGHCX Vanguard Health Care 2.15%
{% mutualfund VTSMX %} Vanguard Total Stock Market Index 1.75%
Funds Holding Catamaran
Symbol Mutual Fund Stake
VGHCX Vanguard Health Care 2.37%
VMCIX Vanguard Mid Cap 1.84%
{% mutualfund VTSMX %} Vanguard Total Stock Market Index 1.74%

The Bottom Line

The funds listed above allow investors to gain exposure to UNH and CTRX while remaining diversified. Investors interested in these companies may also be interested in CVS Health (CVS) or Express Scripts (ESRX).

If you’ve enjoyed this article, sign up for the free MutualFunds.com newsletter, we’ll send you similar content weekly.

Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Popular Articles

Read Next

UnitedHealth Group Inc. logo

UnitedHealth to Buy Catamaran: What it Means For Mutual Fund Investors (UNH, CTRX)

Shauna O'Brien

|

Before Monday’s opening bell, UnitedHealth (UNH) reported that it will acquire Catamaran (CTRX). Here’s what the news means for mutual fund investors.

Inside the Deal

UnitedHealth reported its pharmacy business OptumRx has agreed to acquire Catamaran in a $12.8 billion deal, or $61.50 per share. The companies noted that this deal is expected to close in the fourth quarter.

UNH reported that the deal is expected to add 30 cents per share to earnings in 2016.

Merging Will Help the Companies Face Competition

In the merger deal, the two companies are aiming to obtain more favorable prices with pharmaceutical companies, as they face companies like Express Scripts and CVS. The deal will combine the fourth and third largest pharmacy-benefit companies in the U.S.

Mutual Funds to Watch

Investors interested in the two companies may be interested in the funds listed below. These funds currently have the largest stakes in the companies.

Funds Holding UnitedHealth

Symbol Mutual Fund Stake
{% mutualfund FLPSX %} Fidelity® Low-Priced Stock 2.29%
VGHCX Vanguard Health Care 2.15%
{% mutualfund VTSMX %} Vanguard Total Stock Market Index 1.75%
Funds Holding Catamaran
Symbol Mutual Fund Stake
VGHCX Vanguard Health Care 2.37%
VMCIX Vanguard Mid Cap 1.84%
{% mutualfund VTSMX %} Vanguard Total Stock Market Index 1.74%

The Bottom Line

The funds listed above allow investors to gain exposure to UNH and CTRX while remaining diversified. Investors interested in these companies may also be interested in CVS Health (CVS) or Express Scripts (ESRX).

If you’ve enjoyed this article, sign up for the free MutualFunds.com newsletter, we’ll send you similar content weekly.

Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Popular Articles

Read Next

Advertisement

×

Wait! Do you know all the important aspects of mutual funds?

×

Free Advisor Access newsletter emailed to you.

Receive free and exclusive email updates for financial advisors about best performers, news, CE accredited webcasts and more.

Sign up for Advisor Access

Receive email updates about best performers, news, CE accredited webcasts and more.

Disclaimer: By registering, you agree to share your data with MutualFunds.com and opt-in to receiving occasional communications about projects and events. The contents of this form are subject to the MutualFunds.com Privacy Policy. You can unsubscribe at any time.